GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. - Wikidata - awgldk - TriplyDB

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

http://www.wikidata.org/entity/Q30497661

about

Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist The physiological role of the brain GLP-1 system in stress Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications Spinally projecting preproglucagon axons preferentially innervate sympathetic preganglionic neurons Differential Patterns and Determinants of Cardiac Autonomic Nerve Dysfunction during Endotoxemia and Oral Fat Load in Humans.The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure.Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.Cardiovascular biology of the incretin system.Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.Potential Role of Regulator of G-Protein Signaling 5 in the Protection of Vagal-Related Bradycardia and Atrial Tachyarrhythmia.Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes.Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.Liraglutide for weight management: a critical review of the evidence.Potential cardiovascular effects of incretin-based therapies.GLP-1 receptor agonists: a clinical perspective on cardiovascular effects.The impact of current and novel anti-diabetic therapies on cardiovascular risk.Novel metabolic drugs and blood pressure: implications for the treatment of obese hypertensive patients?Mechanisms for the cardiovascular effects of glucagon-like peptide-1.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.The influence of reduced insulin sensitivity via short-term reductions in physical activity on cardiac baroreflex sensitivity during acute hyperglycemia.Serotonergic modulation of the activity of GLP-1 producing neurons in the nucleus of the solitary tract in mouse.Liraglutide suppresses the plasma levels of active and des-acyl ghrelin independently of active glucagon-like Peptide-1 levels in mice.Elevated blood pressure, heart rate and body temperature in mice lacking the XLαs protein of the Gnas locus is due to increased sympathetic tone.Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection.Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control.The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.Cardiovascular Changes After Gastric Bypass Surgery: Involvement of Increased Secretions of Glucagon-Like Peptide-1 and Brain Natriuretic Peptide.Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter.Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety.Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

P2860

Q26749189-0CB170BA-5C3E-4D16-9F5C-2A0B9497EB46 Q28077787-48E9C605-D696-41FD-81CC-CF90DC634E41 Q30531048-BFDE17B6-5DB5-43D2-ABA9-93934B3043AF Q33717424-C53609A5-7970-4208-B988-9C0374F86A8E Q34990224-B4714548-4425-4C57-9571-CEF910AB455B Q35493790-CDEAC4A9-EC48-4E48-9F32-A0F724A91497 Q35761031-7249EA9C-9703-4EA6-B8D5-C0599DFCBEF1 Q36302662-2215AD86-5D5E-4205-90E8-CF95BE6780A4 Q36307536-393EC5A2-891B-4147-9C71-959F7D2AAD40 Q36339639-093BBCC2-3E41-47D4-ABC8-00D7844FE293 Q36484283-BA92D97D-7D41-4423-94C5-EC97682FFDF3 Q36584204-AAAC24B9-2CDA-4666-8059-D19208BBDD44 Q37090754-27AD6F0A-8200-4ECB-9649-BF4F683E155E Q37125983-3A70D871-99D2-4FC6-AF13-A52C073DE6CB Q37193600-89A3E60E-A04E-400A-9D1E-0E6645617DE8 Q37586881-8086A8EC-1ED2-4544-889B-D9039B76A9DB Q37625913-9DCD41BE-4A77-48CF-8417-D427366B0689 Q37635255-7AE90AAA-BB9F-4913-825A-B82A9CD433E0 Q37711170-FE75B80A-D762-4F9D-9DA8-35C411EC050A Q37990619-B0C5BAF1-4F6D-46DD-AA7D-688761CBE2CE Q38002008-03F1ED4D-AB7F-48B5-96FE-5E1C844E73AC Q38062033-514F68CC-AE3F-4CF9-87E8-62A3FFEDB019 Q38128159-AA2F79C5-934F-444F-8C1A-AE6FDE98D1E8 Q38589032-51B50F03-DED7-452E-A82C-D19736422102 Q39042377-B25A5FD8-B984-40B0-9473-1246A1C7F776 Q40425449-58A0C2AE-6913-4817-8854-FE9888E87BA8 Q41069307-667EC3C1-9B20-47D7-927D-96AFF8991A6E Q42091122-6DBD32DA-8015-4B36-85A6-A2007EF2DA4D Q42176063-5F1888DE-7754-461E-8936-BEEC4FE25A90 Q42736812-28CD139A-A7F1-4E02-9156-BB0A867FE517 Q45251961-825B60F2-5C05-4542-A5A6-C5CAF93820AA Q46906226-97A92461-1043-4552-8BD7-B53C36819EEC Q47153467-351E96B2-6242-4788-B067-0075D1C78FA5 Q47223795-FC62A77F-3C28-41F6-876F-C89F0ABD996B Q48273383-9EEF8C00-67D1-49F5-88B0-1F6F59B71D8D Q48486475-43A6681A-100E-41FA-BA10-A35BC1751422 Q51368060-042C8F57-6611-4BFC-A200-4C4316316B4B Q55090958-B775475D-D9C9-44B9-977C-86DF0EF877A8

P2860

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

http://www.wikidata.org/entity/Q30497661

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@ast

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@en

type

label

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@ast

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@en

prefLabel

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@ast

GLP-1 receptor stimulation dep ...... sion to cardiac vagal neurons.

@en

P1433

Q30497661-895E8C2C-A31E-4F6D-A15A-1952F1F4F0A8

P1476

Q30497661-CEAECA5E-E950-4748-9244-7AA5712E7498

P2093

Q30497661-024210F9-D944-4F6C-8971-C34CEB9363B3

Q30497661-04B12467-A8BD-41C1-967B-8B308D536251

Q30497661-0C177F9F-18A8-450C-9E5F-38863813D99E

Q30497661-43857991-D2B1-4B76-9E93-C5C058F0D1B3

Q30497661-6202F1F6-D264-4FD5-BEEC-796B037E7BC1

Q30497661-B2F6B4BA-968D-42C1-9404-F3F0502FCB71

Q30497661-D6363D3E-C5FB-492E-888E-E477EAF6B822

P2860

Q30497661-00FDADAD-6914-486A-B613-F684D06F8F33

Q30497661-02557BB1-963B-4861-B55E-CC4A6A432304

Q30497661-0512575D-5A11-4725-920B-A73ABB9BAA7E

Q30497661-088CDDC3-F973-47E2-B616-8D0C0463A53E

Q30497661-0C5214BC-A3CD-4E93-B566-209F3D3404EF

Q30497661-129D4205-8DEC-4AAC-BE83-631D0B33F0C3

Q30497661-1611EFD4-5E5F-4DEB-9980-B78776C0CD49

Q30497661-19BC2620-01C4-47B3-8307-AA6FD64DBAD5

Q30497661-1C3F7E89-1118-4162-B2BA-30A210973856

Q30497661-20A675BA-3D47-483C-8E58-6A641C0D1C7F

P304

Q30497661-129EA310-B659-4B2B-ACE0-F6CDBD0C36DE

P31

Q30497661-0310BC70-5EEB-4A75-958F-A559EA1F9A93

P356

Q30497661-B38DF92A-FC0A-4464-B663-22AE19CA9588

P433

Q30497661-9FD6A64E-E95D-40F1-8009-DE0DDC018B11

P478

Q30497661-B175150D-CCBE-4560-AA15-1213C9CAEB17

P50

Q30497661-25F63CA3-2578-4EAA-8F9E-E65DA5828070

Q30497661-773CA0F6-C941-42DD-A229-AF510C4EBB6C

P577

Q30497661-89042D20-8EF1-400A-BCFA-17813BFF31B4

P5875

Q30497661-E7F57AFE-34FD-49B5-A33C-6C76478C04EA

P698

Q30497661-84BEF00F-DFCD-4FC3-A4FB-2F1E9238D4CC

P921

Q30497661-B19E5E36-54FD-42BF-8DC4-97811DE14C0C

P932

Q30497661-8EBAD30F-32BD-46FE-B7BD-AED3E310263B

P356

P1433

Cardiovascular Research

P1476

GLP-1 receptor stimulation dep ...... ssion to cardiac vagal neurons

@en

P2093

David Mendelowitz

http://www.w3.org/2001/XMLSchema#string

Kathleen J Griffioen

http://www.w3.org/2001/XMLSchema#string

Mary Rachael Lovett-Barr

http://www.w3.org/2001/XMLSchema#string

Mohamed R Mughal

http://www.w3.org/2001/XMLSchema#string

Ruiqian Wan

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Yazhou Li

http://www.w3.org/2001/XMLSchema#string

P2860

A role for glucagon-like peptide-1 in the central regulation of feeding

Respiratory sinus arrhythmia: endogenous activation of nicotinic receptors mediates respiratory modulation of brainstem cardioinhibitory parasympathetic neurons

The Physiology of Glucagon-like Peptide 1

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Diabetic cardiomyopathy, causes and effects.

Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus.

The biology of incretin hormones.

Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats.

Heart rate variability--a therapeutic target?

Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes.

P304

72-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVQ271

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45827596

http://www.w3.org/2001/XMLSchema#string

P698

20736238

http://www.w3.org/2001/XMLSchema#string

P921

heart rate variability

P932

3002870

http://www.w3.org/2001/XMLSchema#string